LIM domain kinase 1
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 329–638 | Mutation:D460N | ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;298 K;18-24% PEG 3350, 0.2 M potassium citrate | Resolution 2.20 Å R-free 0.252 |
| 2 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain B; UniProt 329–638 | Mutation:D460N | No other associated polymer | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;298 K;18-24% PEG 3350, 0.2 M potassium citrate | Resolution 2.20 Å R-free 0.252 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 5HVJ | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 3S95 Crystal structure of the human LIMK1 kinase domain in complex with staurosporine Deposited 2011-05-31 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
330–637(308 aa)
Fragment:kinase domain (residue 330-637)
|
Not recorded | STU STAUROSPORINE × 1 NA SODIUM ION × 1 GOL GLYCEROL × 9 CL CHLORIDE ION × 1 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.2;293.15 K;24% MPD, 0.1M Tris pH 7.2, 10mM Phenol, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 1.65 Å R-free 0.181 |
| 3S95 Crystal structure of the human LIMK1 kinase domain in complex with staurosporine Deposited 2011-05-31 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
330–637(308 aa)
Fragment:kinase domain (residue 330-637)
|
Not recorded | STU STAUROSPORINE × 1 NA SODIUM ION × 1 GOL GLYCEROL × 2 CL CHLORIDE ION × 1 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 MRD (4R)-2-METHYLPENTANE-2,4-DIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.2;293.15 K;24% MPD, 0.1M Tris pH 7.2, 10mM Phenol, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 1.65 Å R-free 0.181 |
| 5HVK Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1 Deposited 2016-01-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
329–638(310 aa)
Fragment:UNP residues 329-638
|
Mutation:D460N Non-standard monomer:Yes (specific site not provided by mmCIF) | ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;1.2-1.4 M tri-Sodium citrate, 0.1 M sodium acetate, pH 5.5.
4 crystals used.
|
Resolution 3.50 Å R-free 0.310 |
| 5HVK Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1 Deposited 2016-01-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
329–638(310 aa)
Fragment:UNP residues 329-638
|
Mutation:D460N Non-standard monomer:Yes (specific site not provided by mmCIF) | ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;1.2-1.4 M tri-Sodium citrate, 0.1 M sodium acetate, pH 5.5.
4 crystals used.
|
Resolution 3.50 Å R-free 0.310 |
| 5L6W Structure Of the LIMK1-ATPgammaS-CFL1 Complex Deposited 2016-05-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain L
330–637(308 aa)
|
Not recorded | AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;35% pentaerythritol propoxylate 5/4, 0.1 M HEPES pH 7.5, 0.2 M potassium chloride
|
Resolution 2.53 Å R-free 0.284 |
| 5NXC LIM Domain Kinase 1 (LIMK1) In Complex With PF-00477736 Deposited 2017-05-10 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain L
330–637(308 aa)
Fragment:UNP residues 330-637
|
Not recorded | 9DB (2~{R})-2-azanyl-2-cyclohexyl-~{N}-[2-(1-methylpyrazol-4-yl)-9-oxidanylidene-3,10,11-triazatricyclo[6.4.1.0^{4,13}]trideca-1,4,6,8(13),11-pentaen-6-yl]ethanamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;0.1 M HEPES pH 7.0
0.2 M MgCl2
10% PEG8K
|
Resolution 2.25 Å R-free 0.298 |
| 6WLY PAK4 kinase domain in complex with LIMK1 Thr508 substrate peptide Deposited 2020-04-20 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
503–512(10 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;295 K;0.1M Tris-HCl, 2M Na acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K, 2mM peptide
|
Resolution 1.90 Å R-free 0.205 |
| 7ATS The LIMK1 Kinase Domain Bound To LIJTF500127 Deposited 2020-10-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
330–637(308 aa)
|
Not recorded | RXQ N-[3-[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]benzenesulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;20% PEG3350
0.1 M bis-tris-propane pH 7.5
0.2 M potassium thiocyanate
10% ethylene glycol
|
Resolution 2.80 Å R-free 0.312 |
| 7ATU The LIMK1 Kinase Domain Bound To LIJTF500025 Deposited 2020-10-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomer |
Chain A
330–637(308 aa)
|
Not recorded | RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9
0.2 M NaCl
8% jeffamine M-600
0.005 M iron chloride
|
Resolution 2.80 Å R-free 0.316 |
| 7ATU The LIMK1 Kinase Domain Bound To LIJTF500025 Deposited 2020-10-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomer |
Chain B
330–637(308 aa)
|
Not recorded | RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9
0.2 M NaCl
8% jeffamine M-600
0.005 M iron chloride
|
Resolution 2.80 Å R-free 0.316 |
| 7ATU The LIMK1 Kinase Domain Bound To LIJTF500025 Deposited 2020-10-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomer |
Chain C
330–637(308 aa)
|
Not recorded | RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9
0.2 M NaCl
8% jeffamine M-600
0.005 M iron chloride
|
Resolution 2.80 Å R-free 0.316 |
| 7ATU The LIMK1 Kinase Domain Bound To LIJTF500025 Deposited 2020-10-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomer |
Chain D
330–637(308 aa)
|
Not recorded | RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9
0.2 M NaCl
8% jeffamine M-600
0.005 M iron chloride
|
Resolution 2.80 Å R-free 0.316 |
| 7B8W Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470 Deposited 2020-12-13 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
330–637(308 aa)
|
Not recorded | T3B 2-(2-methylpropanoylamino)-~{N}-[2-[(phenylmethyl)-[4-(phenylsulfamoyl)phenyl]carbonyl-amino]ethyl]-1,3-thiazole-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M Ammonium Citrate dibasic, 20% w/v PEG 3350
|
Resolution 2.80 Å R-free 0.286 |
| 7B8W Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470 Deposited 2020-12-13 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
330–637(308 aa)
|
Not recorded | T3B 2-(2-methylpropanoylamino)-~{N}-[2-[(phenylmethyl)-[4-(phenylsulfamoyl)phenyl]carbonyl-amino]ethyl]-1,3-thiazole-5-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M Ammonium Citrate dibasic, 20% w/v PEG 3350
|
Resolution 2.80 Å R-free 0.286 |
| 7B8W Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470 Deposited 2020-12-13 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
330–637(308 aa)
|
Not recorded | T3B 2-(2-methylpropanoylamino)-~{N}-[2-[(phenylmethyl)-[4-(phenylsulfamoyl)phenyl]carbonyl-amino]ethyl]-1,3-thiazole-5-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M Ammonium Citrate dibasic, 20% w/v PEG 3350
|
Resolution 2.80 Å R-free 0.286 |
| 7B8W Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470 Deposited 2020-12-13 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
330–637(308 aa)
|
Not recorded | T3B 2-(2-methylpropanoylamino)-~{N}-[2-[(phenylmethyl)-[4-(phenylsulfamoyl)phenyl]carbonyl-amino]ethyl]-1,3-thiazole-5-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M Ammonium Citrate dibasic, 20% w/v PEG 3350
|
Resolution 2.80 Å R-free 0.286 |
| 8AAU LIM Domain Kinase 1 (LIMK1) bound to LIMKi3 Deposited 2022-07-03 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain L
330–637(308 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 1 LH0 ~{N}-[5-[2-[2,6-bis(chloranyl)phenyl]-5-[bis(fluoranyl)methyl]pyrazol-3-yl]-1,3-thiazol-2-yl]-2-methyl-propanamide × 1 SO4 SULFATE ION × 3 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;277 K;0.1 M acetate pH 4.5, 0.2 M lithium sulfate, 12% PEG8K
|
Resolution 1.74 Å R-free 0.240 |
9 other PDB entries and 17 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | LIMK1_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 6–315; UniProt 329–638 Author chain B; PDBConstruct 6–315; UniProt 329–638 |